Connect with us

Hi, what are you looking for?

Jewish Business News

Health

gut microbiome May Hold the Cure for Autoimmune Disease

TAU study on treatment of Huntington's disease

 

Scientists from the University of Texas Health Science Center at Houston boast that they may have discovered a way to treat Autoimmune Diseases using gut bacteria found in the human body. Their study titled “Resetting microbiota by Lactobacillus reuteri inhibits T reg deficiency-induced autoimmunity via adenosine A2A receptors, ” was published online in The Journal of Experimental Medicine.

Gut microbiome, the bacteria that reside within the gastrointestinal tract which helps the body with all manner of activities from its immune system to digesting food could cause autoimmune diseases if it changes in certain ways.

Please help us out :
Will you offer us a hand? Every gift, regardless of size, fuels our future.
Your critical contribution enables us to maintain our independence from shareholders or wealthy owners, allowing us to keep up reporting without bias. It means we can continue to make Jewish Business News available to everyone.
You can support us for as little as $1 via PayPal at office@jewishbusinessnews.com.
Thank you.

The study states that replacing the missing gut bacteria, or restoring a key metabolite called inosine, could help treat children with a rare and often fatal autoimmune disease called IPEX syndrome.

Bacteria from our digestive systems known as gut bacteria may be useful in treating many different health problems. The human body is filled with over 100 trillion bacteria which constitute 90% of what is in our systems.

B. infantis and L. reuteri, are strains which can help improve the immune system by attacking inflammation, which is a possible cause of depression. The microbes can also affect appetite, sending signals to the brain which tell you that you are full and not hungry anymore by increasing levels of the hormone leptin and suppressing ghrelin. So it could also become the wonder diet pill of the future.

“Our findings suggest that probiotic L. reuteri, inosine, or other A2A receptor agonists could be used therapeutically to control T cell-mediated autoimmunity, ” says Yuying Liu, an associate professor of pediatrics and gastroenterology at the University of Texas and the study’s lead author.

Newsletter



Advertisement

You May Also Like

World News

In the 15th Nov 2015 edition of Israel’s good news, the highlights include:   ·         A new Israeli treatment brings hope to relapsed leukemia...

Entertainment

The Movie The Professional is what made Natalie Portman a Lolita.

Travel

After two decades without a rating system in Israel, at the end of 2012 an international tender for hotel rating was published.  Invited to place bids...

VC, Investments

You may not become a millionaire, but there is a lot to learn from George Soros.

Copyright © 2021 Jewish Business News